Volume 3, Issue 10
Editorialp. 913
The importance of monitoring adverse events in statin, and other, clinical trials
Author(s): Beatrice Alexandra Golomb
Research Updatep. 921
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Author(s): Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG Reimann, Kris De Boeck
Clinical Trail Methodologyp. 927
Designing better trials for epilepsy medications: the challenge of heterogeneity
Author(s): Daniel Friedman, Jacqueline A French
Clinical Trail Methodologyp. 935
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
Author(s): Claudia Soido Falcao do Amaral, Maria de Fatima Bazhuni Pombo March, Clemax Couto SantAnna
Review: Clinical Trail Outcomesp. 943
Insulin degludec in Type 1 diabetes
Author(s): VS Eligar,S Bain
Review: Clinical Trail Outcomesp. 951
Emerging therapies for the treatment of uveitis: clinical trial observations
Author(s): Jamie Lynne Metzinger, C Stephen Foster
Review: Clinical Trail Outcomesp. 979
Novel treatment options for acute myelocytic leukemia
Author(s): Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomesp. 967
Treating pediatric osteosarcoma: recent clinical trial evidence
Author(s): Alexandra K Abrams, Raffi S Avedian, Neyssa Marina
Review: Clinical Trail Outcomesp. 991
Neoadjuvant chemotherapy in bladder cancer
Author(s): Christopher M Tully, Gopa Iyer, Dean F Bajorin
Acknowledgementsp. 1003
